Transgenic mice carrying a tetracycline-inducible, truncated transforming growth factor beta receptor (TβRII)

被引:14
作者
Frugier, T
Koishi, K
Matthaei, KI
McLennan, IS
机构
[1] Univ Otago, Sch Med Sci, Dept Anat & Struct Biol, Neuromuscular Res Grp, Dunedin, New Zealand
[2] John Curtin Sch Med Res, Div Mol Biosci, Canberra, ACT 0200, Australia
关键词
mouse; transgenic; dominant negative receptor; transforming growth factor-beta; doxycycline; tetracycline-inducible expression; neuron;
D O I
10.1002/gene.20115
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The transforming growth factor-betas (TGF beta s) have multiple roles, making genetic analysis of their functions difficult. We therefore developed transgenic mouse lines to disrupt TGF beta signaling using a mechanism that is inducible, reversible, and cell-type specific. The transgenic mouse lines carry an EGFP-pBi-DeltaT-betaRII construct (PTR). The Delta T beta RII element codes for a dominant-negative receptor that is known to disrupt TGF beta signaling. The Delta T beta RII has a c-myc tag. The transgene was silent in the PTR mice, with expression of both EGFP and Delta T beta RII occurring when the PTR mice were crossed with mice that express the tetracycline transactivator (CMV-tTA). The expression of EGFP was repressed by the addition of doxycycline to the drinking water of the PTRxCMV-tTA mice. The PTR mice were then crossed with neuron-specific-tTA mice. Expression of the Delta T beta RII transgene in these mice led to an upregulation of native TGF beta receptor expression, suggesting that neurons can modulate their responsiveness to TGF beta s. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 19 条
  • [1] COREGULATION OF 2 GENE ACTIVITIES BY TETRACYCLINE VIA A BIDIRECTIONAL PROMOTER
    BARON, U
    FREUNDLIEB, S
    GOSSEN, M
    BUJARD, H
    [J]. NUCLEIC ACIDS RESEARCH, 1995, 23 (17) : 3605 - 3606
  • [2] Transgenic animals with inducible, targeted gene expression in brain
    Chen, JS
    Kelz, MB
    Zeng, GQ
    Sakai, N
    Steffen, C
    Shockett, PE
    Picciotto, MR
    Duman, RS
    Nestler, EJ
    [J]. MOLECULAR PHARMACOLOGY, 1998, 54 (03) : 495 - 503
  • [3] Tgfβ2-/-Tgfβ3-/- double knockout mice display severe midline fusion defects and early embryonic lethality
    Dünker, N
    Krieglstein, K
    [J]. ANATOMY AND EMBRYOLOGY, 2002, 206 (1-2): : 73 - 83
  • [4] ISOLATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR HUMAN C-MYC PROTO-ONCOGENE PRODUCT
    EVAN, GI
    LEWIS, GK
    RAMSAY, G
    BISHOP, JM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (12) : 3610 - 3616
  • [5] FILVAROFF EH, 1994, DEVELOPMENT, V120, P1085
  • [6] TEMPORAL CONTROL OF GENE-EXPRESSION IN TRANSGENIC MICE BY A TETRACYCLINE-RESPONSIVE PROMOTER
    FURTH, PA
    STONGE, L
    BOGER, H
    GRUSS, P
    GOSSEN, M
    KISTNER, A
    BUJARD, H
    HENNIGHAUSEN, L
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) : 9302 - 9306
  • [7] PERSISTENT EFFECT OF TGF-BETA-1 ON EXTRACELLULAR-MATRIX GENE-EXPRESSION IN HUMAN DERMAL FIBROBLASTS
    ISHIKAWA, O
    YAMAKAGE, A
    LEROY, EC
    TROJANOWSKA, M
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 169 (01) : 232 - 238
  • [8] Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice
    Kistner, A
    Gossen, M
    Zimmermann, F
    Jerecic, J
    Ullmer, C
    Lubbert, H
    Bujard, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) : 10933 - 10938
  • [9] LAWLER S, 1994, DEVELOPMENT, V120, P165
  • [10] TGF-β knockout and dominant-negative receptor transgenic mice
    Letterio, JJ
    Böttinger, EP
    [J]. MINERAL AND ELECTROLYTE METABOLISM, 1998, 24 (2-3) : 161 - 167